Orthofix International | OFIX - Betriebsergebnis





Betriebsergebnis Veränderung Datum
Accuray USD 4.71M 6.86M 2024-12
AngioDynamics USD -2.51M 5.41M 2025-09
Artivion USD 4.79M 6.85M 2025-12
AtriCure USD 2.49M 2.28M 2025-12
Dexcom USD 255.3M 67.7M 2026-03
EDAP TMS EUR -4.92M 843K 2025-09
Globus Medical USD 181.31M 298.83M 2025-12
Inogen USD -7.79M 728K 2024-09
Insulet USD 146.3M 28.6M 2025-12
Integra LifeSciences USD 66M 54.24M 2025-12
J&J USD 6.62B 1.03B 2026-03
Medtronic USD 1.74B 40M 2025-12
Mesa Laboratories USD 5.78M 2.27M 2024-12
Orthofix International USD 6.12M 1.91M 2025-12
Plus Therapeutics USD -5.74M 1.26M 2025-12
Smith & Nephew USD 440M 50M 2025-12
STAAR Surgical USD -10.93M 29.42M 2025-12
Stryker USD 1.1B 867M 2026-03
Surmodics USD 58K 5.7M 2025-06
Tandem Diabetes Care USD 8.29M 31.16M 2025-12
Teleflex USD 36.34M 445.24M 2025-12
Veracyte USD 24.63M 1.52M 2025-12
Zimmer Biomet Holdings USD 395.1M 92.2M 2026-03